Talphera, Inc. (TLPH)
0.7853
+0.05
(+6.27%)
USD |
NASDAQ |
Nov 20, 16:00
0.7853
0.00 (0.00%)
After-Hours: 20:00
Talphera Gross Profit (TTM) : 0.00 for Sept. 30, 2026
Gross Profit (TTM) Chart
Historical Gross Profit (TTM) Data
| Date | Value |
|---|---|
| September 30, 2026 | 0.00 |
| June 30, 2026 | 0.00 |
| March 31, 2026 | 0.00 |
| December 31, 2025 | 0.00 |
| September 30, 2025 | 0.00 |
| June 30, 2025 | 0.00 |
| March 31, 2025 | 0.00 |
| December 31, 2024 | 0.00 |
| September 30, 2024 | 0.185M |
| June 30, 2024 | 0.185M |
| March 31, 2024 | 0.174M |
| December 31, 2023 | 0.127M |
| September 30, 2023 | -0.168M |
| June 30, 2023 | -0.592M |
| March 31, 2023 | -1.421M |
| December 31, 2022 | -1.415M |
| September 30, 2022 | -2.537M |
| June 30, 2022 | -0.9315M |
| March 31, 2022 | -0.6885M |
| December 31, 2021 | -1.176M |
| September 30, 2021 | -0.5065M |
| June 30, 2021 | -2.171M |
| March 31, 2021 | -0.02M |
| December 31, 2020 | -0.616M |
| September 30, 2020 | -1.197M |
| Date | Value |
|---|---|
| June 30, 2020 | -2.254M |
| March 31, 2020 | -4.677M |
| December 31, 2019 | -4.517M |
| September 30, 2019 | -3.999M |
| June 30, 2019 | -2.957M |
| March 31, 2019 | -2.019M |
| December 31, 2018 | -1.825M |
| September 30, 2018 | -1.422M |
| June 30, 2018 | -1.466M |
| March 31, 2018 | -2.419M |
| December 31, 2017 | -2.664M |
| September 30, 2017 | 0.832M |
| June 30, 2017 | 2.161M |
| March 31, 2017 | 4.60M |
| December 31, 2016 | 5.042M |
| September 30, 2016 | 1.246M |
| June 30, 2016 | 0.459M |
| March 31, 2016 | -1.096M |
| December 31, 2015 | -0.522M |
| September 30, 2015 | 0.00 |
| June 30, 2015 | 0.00 |
| March 31, 2015 | -0.085M |
| December 31, 2014 | -0.152M |
| September 30, 2014 | 27.30M |
| June 30, 2014 | 27.30M |
Gross Profit Definition
Annual, Interim and Preliminary Items - Commercial, Other Financial Companies
Gross Profit (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit (TTM) Benchmarks
| Relmada Therapeutics, Inc. | 0.00 |
| Journey Medical Corp. | 41.70M |
| ANI Pharmaceuticals, Inc. | 553.08M |
| Corcept Therapeutics, Inc. | 949.55M |
| Veru, Inc. | -0.113M |